BDBM562791 (R)-2-((2S,3R)-2,3-Bis(4-chlorophenyl)-5-oxomorpholino)pentanoic acid::US11407721, Example 37

SMILES CCC[C@@H](N1[C@@H]([C@@H](OCC1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(O)=O

InChI Key InChIKey=NHDJKSJILSOCFS-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 562791   

TargetE3 ubiquitin-protein ligase Mdm2 [1-188](Human)
Amgen

US Patent
LigandChemical structure of BindingDB Monomer ID 562791BDBM562791(US11407721, Example 37 | (R)-2-((2S,3R)-2,3-Bis(4-...)
Affinity DataIC50: 2.13E+3nMAssay Description:The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2 [1-188](Human)
Amgen

US Patent
LigandChemical structure of BindingDB Monomer ID 562791BDBM562791(US11407721, Example 37 | (R)-2-((2S,3R)-2,3-Bis(4-...)
Affinity DataIC50: 8.87E+3nMAssay Description:As the potencies of the HDM2 inhibitors increased, an improved HTRF assay (HTRF2 assay) was developed. All assay conditions remained the same as desc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2 [1-188](Human)
Amgen

US Patent
LigandChemical structure of BindingDB Monomer ID 562791BDBM562791(US11407721, Example 37 | (R)-2-((2S,3R)-2,3-Bis(4-...)
Affinity DataIC50: 1.11E+4nMAssay Description:This assay was run using the same conditions as the HTRF1 assay except that 20 uL of GST-hMDM2 was incubated with 1.0 ul of diluted compound.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent